Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

(d) On February 1, 2021, the Company's Board of Directors expanded the size of the Board of Directors from seven to eight members and appointed Ibrahim Gokcen as a director effective immediately. Mr. Gokcen is a member of the class of directors with a term expiring at the January 2023 Annual Meeting. Mr. Gokcen has been appointed to serve on the Audit Committee and the Corporate Governance and Nominating Committee.

Mr. Gokcen will receive compensation for serving as a director consistent with the description of compensation of non-employee directors included in the section entitled "Compensation of Directors" in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on November 24, 2020.

Mr. Gokcen has entered into an Indemnification Agreement with the Company in the form attached as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on October 19, 2018.

There are no arrangements or understandings between Mr. Gokcen and any other person pursuant to which Mr. Gokcen was appointed as a director, and there are no transactions between Mr. Gokcen and the Company that would be required to be reported under Item 404(a) of Regulation S-K.

Item 7.01. Regulation FD Disclosure.

A copy of the press release announcing Mr. Gokcen's appointment to the Company's Board of Directors is furnished herewith as Exhibit 99.1 and is hereby incorporated by reference into this Item 7.01. In accordance with General Instruction B.2 of Form 8-K, the information contained in this Item 7.01 and the press release are being furnished under Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liabilities of that section, nor shall such information and exhibit be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.






10.1      Form of Indemnification Agreement between the Company and its Officers
        and Directors, previously filed as Exhibit 10.1 with the Company's Current
        Report on Form 8-K filed on October 19, 2018.

99.1      Press Release, dated February 1, 2021, issued by the Company.

104     Cover Page Interactive Data File (embedded within the Inline XBRL
        document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses